LIN
Linde plc
NASDAQ · Basic Materials · Chemicals - Specialty · GB
$477.57
−0.96%Year over year
Reported trailing growth
- Revenue
- +6.6%
- EBITDA
- +4.7%
- EBIT
- +13.5%
- EPS
- +10.2%
- Free cash flow
- -1.9%
- Operating cash flow
- +5.8%
Forward estimates
Based on analyst estimates
- Revenue
- +5.1%
- EBITDA
- +17.1%
- EPS
- +20.2%
Three-year CAGR
- Revenue
- +0.6%
- EBITDA
- +9.2%
- EBIT
- +11.4%
- Net income
- +18.5%
- EPS
- +20.9%
- Free cash flow
- -3.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026